Patents Assigned to BayGen Pharm Technology Co., Ltd.
  • Publication number: 20120065171
    Abstract: Novel Fostriecin (or FST) derivatives represented by formula (I), the pharmaceutical compositions and preparation methods thereof. The pharmaceutical uses of these compounds, especially the use for the preparation of pharmaceutical compositions for treating tumor, inhibiting cell over growth, or lowering myocardial infarction and the injury to cells.
    Type: Application
    Filed: October 1, 2010
    Publication date: March 15, 2012
    Applicants: Dalian University of Technology, BayGen Pharm Technology Co., Ltd.
    Inventors: Li Tang, Rongguo Qiu